You are using a web browser with JavaScript disabled. Some of the features of this website may not function as intended.
[Automatic translation disclaimer]
INQ000177801 – Joint witness statement of Chris Llewelyn and Mark Lloyd, dated 20/04/2023
Royal Pharmaceutical Society – Appointment of Recognised Legal Representative – dated 4 July 2023